ESAB Corp·4

May 12, 4:47 PM ET

Phillipps Stephanie M 4

4 · ESAB Corp · Filed May 12, 2026

Research Summary

AI-generated summary of this filing

Updated

ESAB Director Stephanie Phillipps Receives Equity Award

What Happened

  • Stephanie M. Phillipps, a director of ESAB Corp (ESAB), was the recipient of two equity awards reported on a Form 4 dated 2026-05-12 for transactions on 2026-05-08. She was granted stock options covering 2,647 shares that vested and became exercisable on the grant date, and 813 deferred stock units (DSUs) representing the contingent right to one share each. Both awards are reported with an acquisition price of $0 (derivative awards), so no cash changed hands at grant.

Key Details

  • Transaction date: May 8, 2026; Form 4 filed May 12, 2026 (filing appears timely).
  • Awards:
    • 2,647 stock-option shares (derivative) — grant price $0; footnote: options vested and became exercisable on the grant date.
    • 813 deferred stock units (derivative) — grant price $0; footnotes: each DSU equals a contingent right to one share; DSUs vest in a single installment on June 1, 2027 and will be settled in ESAB common stock after the director’s separation from the company.
  • Shares owned after the transaction: not disclosed in the provided filing excerpt.
  • Transaction code: A = Award/Grant. No sale or cash purchase reported.

Context

  • These are derivative awards, not open-market purchases or sales. The 2,647-option grant vested immediately (per footnote) and thus became exercisable, but the filing does not show an exercise or sale — only the grant/vesting event. The 813 DSUs are subject to future vesting and settlement timing and will not convert to shares until vesting and post‑separation settlement as described. Awards reported at $0 are common for option/DSU grants and do not reflect immediate cash compensation received.

Insider Transaction Report

Form 4
Period: 2026-05-08
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-05-08+2,6472,647 total
    Exercise: $100.94From: 2026-05-08Exp: 2033-05-07Common stock, par value $0.001 (2,647 underlying)
  • Award

    Deferred Stock Units

    [F2][F3]
    2026-05-08+813813 total
    Common stock, par value $0.001 (813 underlying)
Footnotes (3)
  • [F1]These stock options vested and became exercisable on the grant date.
  • [F2]Each deferred stock unit represents a contingent right to receive one share of ESAB common stock.
  • [F3]These deferred stock units vest in a single installment on June 1, 2027. Once vested, the units will be settled in ESAB common stock after the director's separation from the Company.
Signature
/s/ Curtis E. Jewell, Attorney-in-Fact|2026-05-12

Documents

1 file
  • 4
    wk-form4_1778618853.xmlPrimary

    FORM 4